HOUSTON, July 7 Cyberonics, Inc. (Nasdaq: CYBX)today announced that Greg Browne, Chief Financial Officer, will present at theCollins Stewart Fourth Annual Growth Conference in New York City onWednesday, July 9, 2008 at 1:00 PM EDT. Presentation slides will be availableon-line at http://www.cyberonics.com by 8:00 AM EDT on Wednesday,July 9, 2008. Collins Stewart will host a webcast of the presentation liveand by replay at http://www.wsw.com/webcast/clst/cybx/. The replay will beavailable for 90 days following the conference. The presentation can also beaccessed at http://www.cyberonics.com by clicking on the link for thiswebcast. Access to the webcast is not password protected.
ABOUT VNS THERAPY AND CYBERONICS
Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with coreexpertise in neuromodulation. The company developed and markets the VagusNerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for thetreatments of refractory epilepsy and treatment-resistant depression. The VNSTherapy System uses a surgically implanted medical device that delivers pulsedelectrical signals to the vagus nerve. Cyberonics markets the VNS TherapySystem in selected markets worldwide.
Additional information on Cyberonics, Inc. and VNS Therapy(TM) isavailable at http://www.cyberonics.com and http://www.vnstherapy.com.CONTACT INFORMATION: Greg Browne, CFO Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281) 228-7262 Fax: (281) 218-9332 firstname.lastname@example.org
SOURCE Cyberonics, Inc.